As your dose climbs from the starting level toward your therapeutic range, your appetite suppression deepens, which can make hitting protein targets feel harder
Nonetheless, given the heterogeneity of available data and the presence of residual uncertainty, a cautious and individualized clinical approach remains warranted
No significant NAION risk was observed in semaglutide users at 1 month (HR 2.99), 3 months (HR 1.33), 6 months (HR 1.79), or 1 year (HR 1.94) after starting treatment
Free radicals from UV exposure, pollution, and other environmental stressors can damage skin cells and stimulate melanin production
Clinical studies suggest both medications can produce significant weight loss when used alongside lifestyle support
These findings emphasize the importance of personalized treatment approaches that integrate metabolic, genetic, and environmental factors to optimize therapeutic outcomes